---
figid: PMC8392322__biomedicines-09-01051-g003
figtitle: Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8392322
filename: biomedicines-09-01051-g003.jpg
figlink: /pmc/articles/PMC8392322/figure/biomedicines-09-01051-f003/
number: F3
caption: Targeting the JAK-STAT signaling pathway in AML. Representation of multiple
  JAK (red) and STAT (blue) inhibitors in clinical trials. Small interfering RNAs
  (siRNAs) and decoy oligodeoxynucleotide (dODN) are presented in italics.
papertitle: The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia.
reftext: Bernhard Moser, et al. Biomedicines. 2021 Aug;9(8):1051.
year: '2021'
doi: 10.3390/biomedicines9081051
journal_title: Biomedicines
journal_nlm_ta: Biomedicines
publisher_name: MDPI
keywords: STAT | JAK | acute myeloid leukemia | AML | tyrosine kinase inhibitor |
  FLT3
automl_pathway: 0.9133554
figid_alias: PMC8392322__F3
figtype: Figure
redirect_from: /figures/PMC8392322__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8392322__biomedicines-09-01051-g003.html
  '@type': Dataset
  description: Targeting the JAK-STAT signaling pathway in AML. Representation of
    multiple JAK (red) and STAT (blue) inhibitors in clinical trials. Small interfering
    RNAs (siRNAs) and decoy oligodeoxynucleotide (dODN) are presented in italics.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK1
  - JAK2
  - STAT3
  - STAT5A
  - STAT5B
  - FLT3
---
